Clinical Trial Update: HLA-B*5701 And Hypersensitivity To Abacavir

View source ↗

Summary

An update on a clinical trial investigating whether HLA-B*57:01 genotype status predicts hypersensitivity to abacavir in HIV-infected individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Ziagen (Abacavir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection | Status: COMPLETED